Tolazoline hydrochloride

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C10H12N2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E669Z6S1JG, chemically known as 4,5-dihydro-2-(phenylmethyl)-1h-imidazole monohydrochloride but more generally known as tolazoline hydrochloride, which bears US NIH Compound Identifier 6048. European Medicines Agency schedules Tolazoline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04906MIG. Most nations, for tariff and trade purposes, schedule tolazoline hydrochloride under HS 29332990 and SITC 51573. As of Q4 2014, TOLAZOLINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Tolazoline hydrochloride bears US NLM identifiers UMLS ID C0770500 and NCI Concept Code C66609. SMILES: C1CCC(CC1)CC2=NCCN2.CL.